Lumenis (LMNS) Stock Price, News & Analysis

Company Overview

Lumenis Ltd. (Lumenis) is a provider of energy-based, minimally invasive clinical solutions. The Company operates through three segments: surgical, ophthalmic and aesthetic. The Company offers energy-based solutions for medically necessary and elective procedures, primarily for the aging population. Its solutions include the holmium laser, the Lumenis Pulse 120H, used for urologic applications; the VersaPulse PowerSuite platform which uses holmium lasers for urologic applications; the M22 multi-energy, a multi-application platform for the treatment of various skin conditions, and the Selecta multi-modality platform for retinal, secondary cataract and glaucoma therapies. It offers products to hospitals, outpatient clinics, ambulatory surgery centers, physicians' offices, private clinics and aesthetic chains. Its locations include Yokneam, Israel, where surgical and aesthetic products are manufactured, and Salt Lake City, Utah, where ophthalmic products are manufactured.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

LMNS Stock Analysis - Frequently Asked Questions

How were Lumenis' earnings last quarter?

Lumenis Ltd. (NASDAQ:LMNS) released its earnings results on Tuesday, May, 12th. The medical equipment provider reported $0.06 EPS for the quarter, missing the consensus estimate of $0.11 by $0.05. The company's quarterly revenue was up 4.1% on a year-over-year basis.

What other stocks do shareholders of Lumenis own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Lumenis investors own include Momentus (MNTS), Nano-X Imaging (NNOX), Supernus Pharmaceuticals (SUPN), Aralez Pharmaceuticals (ARLZ), Omeros (OMER), Performant Financial (PFMT) and Sientra (SIEN).

Company Calendar

• Last Earnings: 5/12/2015
• Today: 4/26/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NASDAQ:LMNS
• CIK: 1004945
• Web: www.lumenis.com
• Phone: +972-4-9599000
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A